Prime Medicine, Inc.

NasdaqGM:PRME Stock Report

Market Cap: US$426.2m

Prime Medicine Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGM:PRME Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
15 Feb 24BuyUS$20,000,000Arch Venture Partners, L.P.Company3,200,000US$6.25

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of PRME?
Owner TypeNumber of SharesOwnership Percentage
General Public68,9630.054%
Public Companies11,006,1638.63%
Individual Insiders25,499,10420%
VC/PE Firms30,519,09223.9%
Institutions60,502,25847.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 38.3%.


Top Shareholders

Top 25 shareholders own 93.14% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15.8%
David Liu
20,156,945US$67.3m0%no data
12.1%
Arch Venture Partners, L.P.
15,456,594US$51.6m0%4.97%
11.8%
GV Management Company, LLC
15,062,498US$50.3m0%2.86%
8.63%
Bristol-Myers Squibb Company
11,006,163US$36.8m0%no data
4.99%
Nikko Asset Management Co., Ltd.
6,372,910US$21.3m96.8%0.01%
4.79%
Newpath Management, L.P.
6,105,679US$20.4m0%no data
4.44%
ARK Investment Management LLC
5,660,719US$18.9m-7.61%0.14%
4.2%
T. Rowe Price Group, Inc.
5,353,248US$17.9m1.55%no data
4.13%
BlackRock, Inc.
5,266,775US$17.6m3.06%no data
3.83%
The Vanguard Group, Inc.
4,890,313US$16.3m-19.6%no data
3.42%
Keith Gottesdiener
4,361,078US$14.6m0%no data
2.93%
Impresa Management LLC
3,736,707US$12.5m-4.71%6.63%
1.72%
Millennium Management LLC
2,198,240US$7.3m65.2%0.01%
1.63%
Redmile Group, LLC
2,074,350US$6.9m0%0.36%
1.4%
Mwg Management Ltd.
1,792,210US$6.0m0%6.99%
1.07%
Geode Capital Management, LLC
1,359,979US$4.5m4.89%no data
0.9%
State Street Global Advisors, Inc.
1,146,949US$3.8m3.9%no data
0.84%
Vestal Point Capital, LP
1,070,000US$3.6m138%0.27%
0.81%
Baker Bros. Advisors LP
1,028,466US$3.4m0%0.03%
0.76%
Jeremy Duffield
965,001US$3.2m0%no data
0.7%
Deerfield Management Company, L.P. Series C
896,960US$3.0m0%0.05%
0.59%
Farallon Capital Management, L.L.C.
750,000US$2.5m0%0.01%
0.57%
Greenwich Wealth Management, LLC
733,001US$2.4m12.3%0.14%
0.55%
EcoR1 Capital, LLC
700,000US$2.3m0%0.08%
0.54%
Avidity Partners Management, L.P.
694,000US$2.3m0%0.12%